【个人简介】
朱雯婷，广州医科大学附属第三医院，副主任药师，医学博士，毕业于南方医科大学。广东省药学会免疫抑制药学专家委员会常务委员，广东省精准医学应用学会精准用药分会委员、广东省精准医学应用学会青年博士联盟委员，广州市医院协会药学专业工作分会委员。主持广州市校联合项目、广州地区中医药重大科技项目等科研项目4项，以第一作者发表SCI论文11篇，累计影响因子超60分。
【联系邮箱】zhuwenting456@126.com
【研究方向类别】
专业学位：工业药学
（临床药剂学）
【具体研究方向】
药物抗肿瘤药理及靶向递送系统
【主要科研项目】
[1] 广州市校联合项目，2024A03J0188，2024.01至2025.12，20万，在研，主持；
[2] 广州医科大学2024年度科研能力提升计划-科研起步，2024SRP104，朱雯婷，8万，2024.01-2025.12
[3] 广州地区中医药重大科技项目，2025QN014, 10万，2025.01-2027.12
[4] 广州市教育局高校科研项目, 2024312182, 朱雯婷，2万，2025.01-2026.12
【所获荣誉和奖励】
无
【主要论文及著作（代表性）】
(1)Yu H, Liu S, Yuan Z, Huang H, Yan P, Zhu W*. Targeted co-delivery of rapamycin and oxaliplatin by liposomes suppresses tumor growth and metastasis of colorectal cancer. Biomed Pharmacother. 2024;178:117192.
(2)Zhu WT#, Yu H#, Jia ML, Lin CY, Yuan ZW, Tan XX, Yan PK*. Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation[J]. Int J Pharm,2023,644:123316.
(3)Zhu WT#, Zeng XF#, Yanghua, Jia ML, Zhang W, Liu W*, Liu SY*. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway. Int J Nanomedicine. 2023;18:2677-2691.
(4)Zeng X#, Liu S, Yang H, Jia ML, Liu W, Zhu WT*. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1alpha/VEGF and EMT signalling pathways[J]. J Pharm Pharmacol,2023;75(11):1405-1417.
(5)Yu H#, Zhu W#, Lin C, et al. Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancer[J]. Biomater Sci,2023,12(1):116-133
(6)Jia M, Tan X, Yuan Z, Zhu WT*, Yan PK*. Nanoliposomes Encapsulated Rapamycin/Resveratrol to Induce Apoptosis and Ferroptosis for Enhanced Colorectal Cancer Therapy[J]. J Pharm Sci,2024.
(7)Jia M, Yuan Z, Yu H, Feng S, Tan X, Long Z, Duan Y, Zhu W*, and Yan P*. Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment[J]. Biomed Pharmacother,2024,176:116883.
(8)Liu XM#, Zhu WT#, Jia ML, Li YT, Hong Y, Liu ZQ*, Yan PK*. Rapamycin liposomes combined with 5-Fluorouracil inhibits angiogenesis and tumor growth of APC (Min/+) mice and AOM/Dss-induced colorectal cancer mice. INT J NANOMED. 2022.17:5049-5061.
